Shine-On BioMedical Co.,Ltd. (TPEX:6926)
69.60
-0.90 (-1.28%)
Oct 31, 2025, 1:25 PM CST
Shine-On BioMedical Company Description
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products.
It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody.
The company was founded in 2021 and is based in Taichung, Taiwan.
Shine-On BioMedical Co.,Ltd.
| Country | Taiwan |
| Founded | 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 22 |
| CEO | Hongzhe Jiang |
Contact Details
Address: No. 633, Taiwan Blvd. Taichung, 407569 Taiwan | |
| Phone | 886 4 2327 2888 |
| Website | shineon-bio.com |
Stock Details
| Ticker Symbol | 6926 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006926009 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hongzhe Jiang | Chief Executive Officer |